BioHealth Capital Region – Regional Life Sciences Roundup – July 24, 2026

· Published · Updated · 7 min read · BioHealth Capital Region
BioHealth Capital Region – Regional Life Sciences Roundup – July 24, 2026
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly.

Infrastructure is having a moment in the BioHealth Capital Region. It’s easy to focus solely on the breakthrough science, but this week’s news reveals a deeper trend: the region is actively hardening its operational backbone. From Virginia’s push for domestic manufacturing capacity to the expansion of wet labs in Richmond and new investments in gene therapy patient access, the focus is shifting toward scaling the systems that move products from the bench to the bedside.

For founders, investors, and industry leaders, this isn’t just background noise, it’s a clear signal on where the next wave of opportunity lies. As the region matures its capacity to carry innovation through commercialization and direct patient delivery, the competitive advantage is rapidly shifting toward those who are building with these operational realities in mind. Below, we’re tracking the capital, the leadership moves, and the infrastructure milestones that are quietly, but decisively, positioning the region for its next phase of growth.

Financial

Tracking the capital moving through the BioHealth Capital Region — funding rounds, M&A activity, and investment trends shaping Maryland, DC, and Virginia’s life sciences companies.

Virginia Secures $15.9M to Advance Domestic Drug Manufacturing

The push to bring critical medicine manufacturing back to the U.S. is gaining momentum. Virginia’s Advanced Pharmaceutical Manufacturing Tech Hub secured a $15.97 million federal investment. Led by Civica with support from Phlow and industry partners, the initiative strengthens domestic pharmaceutical supply chains while positioning Virginia as a growing hub for advanced manufacturing. Read More > 

TEDCO Invests in Baltimore MedTech Startup Veina to Advance Blood Collection Innovation

Johns Hopkins-born startup Veina has received a $50,000 TEDCO Technology Advancement Grant to advance itsa blood collection device designed to reduce hemolysis, repeat draws, and delays in patient care. The investment highlights Maryland’s continued efforts to move university innovations from the lab toward clinical impact. Read More >

Virginia Invests Nearly $15M in Gene Therapy Access 

Virginia is committing nearly $15 million to make high-cost sickle cell gene therapies more accessible through Medicaid, creating a new funding pathway for next-generation treatments.

The investment highlights how state-level reimbursement strategies are becoming critical to bringing advanced therapies from FDA approval to real-world patient access. Read More > 

People

Who we’re buzzing about this week — the leadership moves, board appointments, and rising names shaping the region’s life sciences community.

Kymanox  Appoints Jessie Mastropietro as Senior Project Manager

Kymanox appoints Jessie Mastropietro as Senior Project Manager, bringing nearly a decade of drug-delivery device expertise to support combination product development. Her experience in device innovation, clinical evaluation, and engineering leadership strengthens Kymanox’s efforts to help life sciences companies advance products toward commercialization. Read More >

Victor Dzau Joins United Therapeutics Board of Directors

United Therapeutics welcomes physician-scientist and global health leader Victor Dzau, M.D., to its Board of Directors as the company advances its mission to develop therapies for rare diseases and expand access to transplantable organs. With decades of leadership across healthcare, research, and global health, Dr. Dzau brings extensive expertise to guide United Therapeutics’ next phase of innovation. Read More > 

Workforce

The hiring activity, team expansions, and talent trends driving growth across Maryland, DC, and Virginia’s life sciences and biotech employers.

Epidarex Capital Elevates C-Suite Leadership Team Following Launch of $145M Life Sciences Fund

Transatlantic venture firm Epidarex Capital announced several key executive promotions across its Bethesda, Maryland, and UK offices. Co-founder Kyp Sirinakis is transitioning to Founding Partner, while Dr. Elizabeth Roper and Dr. Peter Finan step up as Managing Partners, and Anthony Voveris assumes the role of Chief Financial Officer. The leadership evolution positions the firm to deploy its recently closed $145 million Epidarex Capital IV fund to back high-growth biotech startups and scale its investment workforce. Read More >

BioHealth Innovation EIRs Scale Mentorship Bench for Mid-Atlantic Startups

BioHealth Innovation (BHI) has expanded its advisory bench with the addition of life science veterans Dr. Caroline Popper and Julie Wilkinson as Entrepreneurs-in-Residence (EIRs). Bringing over 60 years of combined experience across FDA regulatory pathways, AI healthcare frameworks, and commercialization strategies, the duo is actively guiding early-stage medtech and diagnostic founders through market-entry strategies ahead of September’s 12th Annual BioHealth Capital Region Week. Read More >

Who’s hiring?! 

AstraZeneca

A global, science-led, patient-focused pharmaceutical company advancing prescription medicines across 85+ countries, AstraZeneca is recognized for building an inclusive workplace where employees can grow, thrive, and make an impact through science. 

With a major R&D campus in Gaithersburg, MD  driving discovery and development, and a biopharmaceutical manufacturing site in Frederick, MD supporting the advancement of therapies, AstraZeneca is strengthening Maryland’s biohealth ecosystem. 

They are currently hiring across 110+ roles across both campuses.  Apply Now > 

Other employers and available roles we’re paying attention to this week: 

  • Otsuka (Baltimore, MD) is hiring a Pharmaceutical Sales – Neuroscience Specialist | Apply Now >
  • Psomagen (Rockville, MD) is hiring a Human Resources Coordinator Associate – Mid Level | Apply Now > 
  • Thermofisher Scientific (Rockville, MD)  is hiring a Project Support Associate, Client Services | Apply Now > 
  • IBT Bioservices (Rockville, MD) is hiring a Administrative Assistant  | Apply Now > 
  • MacroGenics (Rockville, MD) is hiring a Senior Manager, Business Development | Apply Now > 

Clinical + Commercial

The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across the BioHealth Capital Region.

Immunomic Therapeutics Announces First Patient Dosed in Phase 1 Trial of Cancer Vaccine Candidate ITI-5000

Rockville-based Immunomic Therapeutics has officially dosed the first participant in its VITALITI Phase 1 trial evaluating ITI-5000, an innovative self-amplifying RNA (saRNA) cancer vaccine. Built on the company’s proprietary UNITE® platform, ITI-5000 aims to generate targeted T cell immune responses to prevent disease recurrence in patients with Stage II–III triple-negative breast cancer (TNBC).  Read More >

James City County Achieves Virginia’s First Drone AED Delivery in Breakthrough Test Flights

In a pioneering leap for emergency response technology, James City County became the first locality in Virginia, and only the second nationwide, to deploy AED-equipped drones in real-world test trials. Supported by an AHA grant alongside VCU and Duke researchers, the project integrates public safety drone dispatches with 911 coaching to empower bystanders during critical cardiac emergencies. Read More >

MacroGenics Reports Clinical Progress in Phase 1 Trial for B7-H3 Antibody-Drug Conjugate

Rockville-based MacroGenics, Inc. released a fresh clinical update on its ongoing Phase 1 study evaluating MGC026, a novel B7-H3-directed antibody-drug conjugate (ADC). The clinical-stage biopharmaceutical leader is preparing to present dose escalation and tumor-reduction data for the candidate, which utilizes a topoisomerase I inhibitor payload to treat patients with advanced solid tumors across the region and beyond. Read More >

Ecosystem

The partnerships, programs, and policy moves building the BioHealth Capital Region’s life sciences infrastructure — and the organizations driving it forward.

Building Green: How Maryland’s Biotech Facilities Became a Sustainability Proving Ground

Maryland’s life sciences hub is setting a national standard by merging cutting-edge lab design with aggressive sustainability goals. From LEED-certified biomanufacturing plants to energy-efficient HVAC systems designed for high-throughput labs, local developers and pharma giants are proving that eco-friendly infrastructure can drive operational efficiency without compromising clinical standards. Read More >

Virginia’s Bio+Tech Center Expands Wet Labs and Workspace for High-Growth Startups

Richmond-based Activation Capital is expanding its Bio+Tech Center incubator inside the Virginia Bio+Technology Research Park, adding over 10,500 square feet and 13 new wet labs. In partnership with Virginia Commonwealth University (VCU) and backed by federal and state funding, this move more than doubles the center’s lab capacity to support early-stage biotech research, product development, and commercialization. Read More >

Beyond the Big Build: How Frederick’s Ecosystem Is Growing Around Biomanufacturing

A thriving life sciences hub takes more than a single anchor investment. Frederick County’s latest developments, including Minkoff’s industrial park acquisition and TIPCO Technologies’ facility expansion,  highlight how suppliers, flexible spaces, and innovation infrastructure are keeping pace with the region’s rapid biomanufacturing growth. Read More >

Other [Good] Reads 

Editor’s picks from across the web — the stories, videos, and podcasts shaping the conversation in DMV biotech and life sciences this week.

Your Guide to Life Sciences Career Pathways with BioHub Maryland

Looking to break into life sciences or explore your next career move? BioHub Maryland’s Career Roadmap lets you search for your dream job, discover the skills and education needed to succeed, and navigate career pathways with resources tailored to Maryland’s growing life sciences workforce. Read More >

On the Calendar 

A few of the upcoming events, conferences, and networking opportunities across the BioHealth Capital Region’s life sciences ecosystem that you don’t want to miss.

Intern Mixer 

Thursday, July 30  •  4-6 PM EDT • Baltimore, MD 

Hosted by Connect Labs Baltimore, BioPark Events & Connect Labs by Wexford | Register Now >

Artificial Intelligence and Public Health (AIxP) | October 2026 

Friday, July 31 • Early Bird Registration Deadline • Baltimore, MD 

Hosted by National Network of Public Health Institutes (NNPHI)  | Register Now >

EWIB– Capital Region: From Patent to Exit 

Thursday, August 6  • 4:30 -6:30  PM EDT • Frederick, MD

Hosted by Women in Bio |  Register Now >


Did we miss something!? Drop us a line →

Stay connected to BioHealth Capital Region life sciences.

🔍 Explore companies → · 💼 Browse jobs → · 📅 See events → · 📰 Read more →

Get the BioHealth Capital Region Roundup every Friday.
The week’s most important life sciences news from BioHealth Capital Region— delivered to your inbox.

Get Connected →


?

Vaanishree Joshi BioBuzz Fellow

Stay in the Loop

Get the latest life science news delivered to your inbox weekly.